Continued Access to Avutometinib in Combination With Defactinib in Patients With Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)
Clinical trial NCT07747506 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07747506
- Sponsor
- Verastem, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-03
- Primary completion
- 2027-08-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.